Skip to content
Clinical Trials for Alzheimer's Disease

Jacksonville, Florida

Alzheimer's disease clinical trials in Jacksonville, FL

7 Alzheimer's disease studies are recruiting participants at sites in Jacksonville as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Jacksonville at a glance

  • 7 studies are recruiting at a site in Jacksonville.
  • By phase: Phase 1/2 (1), Phase 3 (3), Phase 4 (1), No phase (1), Observational (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (5), university, hospital or other (2).
  • Most recent update to one of these records: October 28, 2026.

Studies recruiting in Jacksonville

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Jacksonville Center for Clinical Research
    Registry record
    NCT07602582 · updated
  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Jacksonville Center for Clinical Research
    Registry record
    NCT06976203 · updated
  3. Dominantly Inherited Alzheimer Network (DIAN)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT00869817 · updated
  4. Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

    • No phase
    • Ages 50 and older
    • All sexes
    Sponsor
    MMI (Medical Microinstruments, Inc.)
    Study site
    Baptist Health Research Institute
    Registry record
    NCT07178210 · updated
  5. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    Mayo Clinic - Jacksonville
    Registry record
    NCT06563895 · updated
  6. Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

    • Phase 4
    • Ages 60 and older
    • Female participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic
    Registry record
    NCT03821857 · updated
  7. Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

    • Phase 1/2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Ashvattha Therapeutics, Inc.
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT05395624 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Ask about studies near Jacksonville

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call